Dietary supplementation with glucan enhances immune fn
Dietary supplementation with glucan enhances immune fn
批准号:
6317216
负责人:
David L. Williams
金额:
$15.47万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-10 至 2003-08-31
关键词:
Peyer's patches RNase protection assay Streptococcus pneumoniae bactericidal immunity blood chemistry dietary supplements flow cytometry folk medicine gel mobility shift assay glucans histochemistry /cytochemistry immunomodulators influenzavirus A laboratory mouse microorganism immunology nuclear factor kappa beta nutrition related tag oral administration polymerase chain reaction serology /serodiagnosis virus diseases
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (APPLICANT'S ABSTRACT): Glucans are natural product polymers of
glucose, which are produced by fungi, certain bacteria and plants. Glucans have
demonstrated the ability to stimulate immunity and increase resistance to
infectious challenge following systemic administration, i.e., N, IP, IM or SQ.
As natural products, glucans are found as fiber in the normal diet.
Additionally, glucans have been identified as components of Chinese, Japanese
and Indian traditional medicines. Recently, several dietary supplements have
appeared on the market which are reported to contain glucan. The manufacturers
have inferred from the scientific literature that dietary supplementation with
glucans will have beneficial effects comparable to those observed with systemic
administration. The development of a dietary supplement which could increase
immunocompetence and enhance resistance to common infections would be of
significant benefit to human health. However, the evidence that dietary
supplementation with glucans will enhance immunity is limited and controversial
and there is no evidence that these supplements will increase resistance to
common infectious diseases. The objectives of this R21 exploratory research
program are to determine whether dietary supplementationwith glucan will
modulate immune function and, more importantly, whether oral glucans will
increase resistance to common infectious diseases. There are two specific aims.
First, we will characterize the local and systemic immunomodulation associated
with dietary supplementation of glucan. Second, we will determine whether oral
administration of (1--3)-(3-D-glucans will enhance resistance to challenge with
the respiratory pathogens, Streptococcus neumoniae or murine adapted influenza
A/PR8/34 HIM virus. At the successful conclusion of this research e will have
established what, if any, effect dietary supplementation with glucan has on
modulating immunocompetence arid whether oral glucans will increase resistance
to infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of an alpha-1 phosphate mannan vaccine against the emerging fungal pathogen Candida auris.
-
批准号:10573467
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2023
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:7939064
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2009
-
负责人:David L. Williams
-
依托单位:
Dietary supplementation with glucan enhances immune fn
-
批准号:6534558
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2001
-
负责人:David L. Williams
-
依托单位:
IMMUNE RECOGNITION OF CANDIDA--ROLE OF CELL WALL
-
批准号:6225237
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2001
-
负责人:David L. Williams
-
依托单位:
BIOMOLECULAR INTERACTION ANALYSIS INSTRUMENTATION
-
批准号:2489127
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1998
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:8235529
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:6628698
-
项目类别:
-
资助金额:$25.39万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:7281703
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:2192894
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:2685082
-
项目类别:
-
资助金额:$16.64万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:7150183
-
项目类别:
-
资助金额:$29.57万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:7679385
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:6498428
-
项目类别:
-
资助金额:$25.39万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:7497484
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:6262619
-
项目类别:
-
资助金额:$25.04万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
Amelioration of Sepsis by Macrophage Activation
-
批准号:8400886
-
项目类别:
-
资助金额:$27.7万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:6698553
-
项目类别:
-
资助金额:$25.39万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:2392260
-
项目类别:
-
资助金额:$16.0万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
-
批准号:2900857
-
项目类别:
-
资助金额:$17.3万
-
财政年份:1996
-
负责人:David L. Williams
-
依托单位:
海外基金